日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ASS1 inhibits liver cancer by promoting CAD ubiquitination and reversing the urea cycle and pyrimidine synthesis imbalance.

ASS1 通过促进 CAD 泛素化和逆转尿素循环和嘧啶合成失衡来抑制肝癌

Ming Zhengnan, Luo Tiao, Zou Zizheng, Luo Wensong, Hu Xiyuan, Chen Ling, Zhou Jiang, Liu Xiaohe, Liu Mingquan, Li Jijia, Luo Junli, Ma Dayou, Liu Suyou, Luo Zhiyong

LM2I leads to CAD ubiquitination and liver cancer suppression through activation of ASS1.

LM2I 通过激活 ASS1 导致 CAD 泛素化和肝癌抑制。

Ming Zhengnan, Luo Tiao, Zou Zizheng, Luo Wensong, Hu Xiyuan, Chen Ling, Zhou Jiang, Liu Xiaohe, Liu Mingquan, Li Jijia, Ma Dayou, Liu Suyou, Luo Zhiyong

[Therapeutic efficacy of ASS1 combined with LOLA in the treatment of hyperammonemia in mice]

[ASS1联合LOLA治疗小鼠高氨血症的疗效]

Luo, Tiao; Ming, Zhengnan; Zou, Zizheng; Luo, Zhiyong

CSE reduces OTUD4 triggering lung epithelial cell apoptosis via PAI-1 degradation

CSE 通过 PAI-1 降解降低 OTUD4 引发肺上皮细胞凋亡

Lijuan Luo, Tiao Li, Zihang Zeng, Herui Li, Xue He, Yan Chen

Systemic Analysis on the Features of Immune Microenvironment Related to Prognostic Signature in Head and Neck Squamous Cell Carcinoma

头颈部鳞状细胞癌免疫微环境特征与预后标志物相关的系统分析

Su, Kaixin; Zhou, Zekun; Yi, Qiao; Liu, Junjie; Luo, Tiao; Cui, Xinyan; Zhang, Haixia